Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study

•We examined pre-diagnosis use of menopausal hormone therapy (MHT) and ovarian cancer-specific mortality.•Estrogen-only and estrogen plus progestin-only therapy were unrelated to ovarian cancer-specific death.•Recency of MHT use was unrelated to ovarian cancer-specific death.

Bibliographic Details
Main Authors: Felix, Ashley S., Bunch, Kristen, Yang, Hannah P., Arem, Hannah, Trabert, Britton, Gierach, Gretchen L., Park, Yikyung, Lowery, William J., Brinton, Louise A.
Format: Online
Language:English
Published: Elsevier 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563575/